Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Clinical trial NCT00700336 · COMPLETED

Trial details

NCT number: NCT00700336
Sponsor: CanBas Co. Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma Solid Tumors

Start date: 2008-05-01
Primary completion: 2012-07-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.